We learn a lot of things in the Cycling Independent Reform Commission (CIRC) report. Particularly concerning the Spanish rider Alberto Contador. We can read that there was no evidence behind the allegations of the UCI covering up Alberto Contador's positive test for clenbuterol at the 2010 Tour de France.

Contador, who won the 2010 Tour de France, returned a positive test on the second rest day of the race. According to the CIRC report, this was because "the Cologne laboratory was able to undertake a more in-depth analysis for AICAR, insulin and clenbuterol."

End of August, Contador was contacted by the UCI to meet the federation about an Adverse Analytical Finding (AAF). Contador was asked and he explained that the low level clenbuterol in his sample was due to contaminated meat. There was many cases in China and Mexico, but no one in Europe. So the CIRC report suggests that there was “good reasons to investigate the matter" before going public with the case again Contador as discussions between the UCI, WADA, and laboratories took place to determine the next cause of action.

But UCI did not want to open a procedure on the bases of the clenbuterol finding only. So the CIRC report does raise the issue of favourable treatment; in particular through interviewees who raised the question of why Contador was allowed to be notified in is home country.

The low level of clenbuterol and the fact that Contador had won the Tour, was not reason enough according to CIRC for special treatment by the UCI and was an example of the UCI's “poor public management of crisis situations."

"The CIRC is of the opinion that the same rules and procedures should have applied to Alberto Contador as to all riders irrespective of his ranking and status."